• 대한치주과학회:학술대회논문집
• /
• 대한치주과학회 2001년도 제41회 종합학술대회 연제초록
• /
• pp.42-42
• /
• 2001

• 대한약학회:학술대회논문집
• /
• 대한약학회 2000년도 춘계총회 및 학술대회
• /
• pp.111.2-112
• /
• 2000

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 2006년도 제45차 춘계학술대회
• /
• pp.27-27
• /
• 2006

• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2001년도 제40차 춘계학술대회
• /
• pp.52.1-52.1
• /
• 2001

• 한국잠사학회:학술대회논문집
• /
• 한국잠사학회 2002년도 Join Meetings of Korean Society of Sericultural Science and Japanse Society of Sericultural Science
• /
• pp.121-121
• /
• 2002

No Abstract, See Full Text

• 한국방사성폐기물학회:학술대회논문집
• /
• 한국방사성폐기물학회 2018년도 추계학술논문요약집
• /
• pp.382-383
• /
• 2018

• 한국방사성폐기물학회:학술대회논문집
• /
• 한국방사성폐기물학회 2018년도 추계학술논문요약집
• /
• pp.380-381
• /
• 2018

• 한국방사성폐기물학회:학술대회논문집
• /
• 한국방사성폐기물학회 2018년도 추계학술논문요약집
• /
• pp.418-419
• /
• 2018

• 대한약학회:학술대회논문집
• /
• 대한약학회 2000년도 NEW STRATEGY FOR DRUG DEVELOPMENT IN POST-GENOMIC ERA(대한약학회)
• /
• pp.175.2-175.2
• /
• 2000

• Clinical Endoscopy
• /
• 제57권1호
• /
• pp.112-121
• /
• 2024

Background/Aims: Since the usefulness of neoadjuvant chemo(radiation) therapy (NAT) for pancreatic cancer has been demonstrated, recurrent biliary obstruction (RBO) in patients with pancreatic cancer with a fully covered self-expandable metal stent (FCSEMS) during NAT is expected to increase. This study investigated the impact of sarcopenia on RBO in this setting. Methods: Patients were divided into normal and low skeletal muscle index (SMI) groups and retrospectively analyzed. Patient characteristics, overall survival, time to RBO (TRBO), stent-related adverse events, and postoperative complications were compared between the two groups. A Cox proportional hazard model was used to identify the risk factors for short TRBO. Results: A few significant differences were observed in patient characteristics, overall survival, stent-related adverse events, and postoperative complications between 38 patients in the normal SMI group and 17 in the low SMI group. The median TRBO was not reached in the normal SMI group and was 112 days in the low SMI group (p=0.004). In multivariate analysis, low SMI was the only risk factor for short TRBO, with a hazard ratio of 5.707 (95% confidence interval, 1.148-28.381; p=0.033). Conclusions: Sarcopenia was identified as an independent risk factor for RBO in patients with pancreatic cancer with FCSEMS during NAT.